Northern Trust Corp Exagen Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Exagen Inc. stock. As of the latest transaction made, Northern Trust Corp holds 18,375 shares of XGN stock, worth $128,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,375

Previous 18,375 -0.0%

Holding current value

$128,441

Previous $75,000 13.33%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.43 - $6.0 $6,390 - $15,780	2,630 Added 16.7%	18,375 $75,000
Q3 2024 Nov 13, 2024	SELL	$1.74 - $3.42 $977 - $1,922	-562 Reduced 3.45%	15,745 $48,000
Q2 2024 Aug 14, 2024	SELL	$1.36 - $2.05 $85 - $129	-63 Reduced 0.38%	16,307 $29,000
Q1 2024 May 14, 2024	SELL	$1.42 - $2.3 $99 - $161	-70 Reduced 0.43%	16,370 $26,000
Q2 2022 Aug 12, 2022	SELL	$4.18 - $7.74 $287,040 - $531,505	-68,670 Reduced 80.68%	16,440 $94,000
Q1 2022 May 13, 2022	SELL	$7.12 - $11.06 $31,634 - $49,139	-4,443 Reduced 4.96%	85,110 $684,000
Q4 2021 Feb 08, 2022	SELL	$8.97 - $14.08 $27,143 - $42,606	-3,026 Reduced 3.27%	89,553 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$10.25 - $15.21 $49,446 - $73,373	-4,824 Reduced 4.95%	92,579 $1.26 Million
Q2 2021 Aug 13, 2021	BUY	$12.4 - $17.92 $542,921 - $784,609	43,784 Added 81.66%	97,403 $1.46 Million
Q1 2021 May 12, 2021	SELL	$13.9 - $22.0 $50,359 - $79,706	-3,623 Reduced 6.33%	53,619 $938,000
Q4 2020 Feb 11, 2021	BUY	$11.19 - $16.05 $637 - $914	57 Added 0.1%	57,242 $755,000
Q3 2020 Nov 16, 2020	SELL	$10.56 - $16.69 $32,978 - $52,122	-3,123 Reduced 5.18%	57,185 $620,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $16.7 $186,472 - $283,098	16,952 Added 39.1%	60,308 $748,000
Q1 2020 May 14, 2020	BUY	$12.7 - $25.95 $81,089 - $165,690	6,385 Added 17.27%	43,356 $691,000
Q4 2019 Feb 14, 2020	BUY	$12.61 - $28.48 $466,204 - $1.05 Million	36,971 New	36,971 $939,000

Others Institutions Holding XGN

# of Institutions

Shares Held

6.17M

Call Options Held

3.4K

Put Options Held

18.4K

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $114M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Exagen Inc. Transaction History